Blog Post
Navigating Regulatory Complexity in Life Sciences: Turning Compliance into a Strategic Advantage
As global regulations continue to evolve, life sciences companies are facing increasing pressure to meet stringent compliance requirements without slowing down innovation or compromising product...
Read More
Blog Post
Engaging Early: FDA’s Collaborative Pathways for AI in Regulatory Applications (Part 3 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More
Blog Post
Sustaining Reliability: Life Cycle Maintenance of AI Models in Drug Development (Part 2 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More
Blog Post
A Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More